The Cell Sciences Imaging Facility (CSIF) Shared Resource provides access to and training in high resolution, state-of-the-art imaging technologies. These technologies are essential tools for studying the molecular, sub-cellular and cellular mechanisms of cancer The CSIF is organized into three interdependent resources: the Fluorescence Microscopy Core (FMC), the Electron Microscopy Core (EMC) and the Array Tomography Core (ATC). The facility's FMC houses three advanced imaging systems that provide confocal, deconvolution, and 2-photon fluorescent light microscopy technologies for imaging both fixed and live cells and tissues. The Facility's EMC offers complete sample preparation and training in both transmission and scanning electron microscopy technologies for ultra structural and immunohistochemical studies. The Facility's ATC provides complete array tomography services, from array generation and labeling to automated imaging of immunolocalized arrays. Additional equipment includes all ancillary equipment necessary for sample preparation and advanced software resources for 3D, 4D interactive volume imaging of data sets, as well as advanced deconvolution software packages. The CSIF's current operating budget is approximately $500,000. The CSIF recovers, on average, 84% of this cost through user fees with the remaining 16% covered by the Cancer Center and institutional funds. Additionally, institutional funds support the growth of the CSIF by funding capital equipment needs not easily funded through grants. Leadership is provided by the CSIF's Advisory Committee. This nine member committee includes Dr. Stephen Smith, a world expert in microscopy, Mr. Mulholland, Director of the CSIF, and seven researchers from the Cancer Center, School of Medicine and School of the Humanities and Sciences. Forty-six Cancer Center members currently use the CSIF resources. Future goals of the CSIF include providing improved live cell and tissue imaging technologies. The CSIF also continues to actively develop its cryo and immuno-EM technologies and is developing correlative methods for light and electron microscopy, all of which will be essential to the study and understanding of the molecular and structural basis of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-07
Application #
8475460
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
7
Fiscal Year
2013
Total Cost
$56,585
Indirect Cost
$4
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Nair, Viswam S; Sundaram, Vandana; Desai, Manisha et al. (2018) Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial. Am J Respir Crit Care Med 197:1220-1223
She, Richard; Jarosz, Daniel F (2018) Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change. Cell 172:478-490.e15
Champion, Magali; Brennan, Kevin; Croonenborghs, Tom et al. (2018) Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response. EBioMedicine 27:156-166
Zhou, Mu; Leung, Ann; Echegaray, Sebastian et al. (2018) Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications. Radiology 286:307-315
Pollom, Erqi L; Fujimoto, Dylann K; Han, Summer S et al. (2018) Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res 59:i11-i18
Nørgaard, Caroline Holm; Jakobsen, Lasse Hjort; Gentles, Andrew J et al. (2018) Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study. PLoS One 13:e0193249
Im, Hogune; Rao, Varsha; Sridhar, Kunju et al. (2018) Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells. Leuk Lymphoma 59:2952-2962
Huang, Min; Zhu, Li; Garcia, Jacqueline S et al. (2018) Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells. Oncotarget 9:11665-11676
Chiou, Shin-Heng; Dorsch, Madeleine; Kusch, Eva et al. (2018) Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Sci Rep 8:14008
Breslow, David K; Hoogendoorn, Sascha; Kopp, Adam R et al. (2018) A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies. Nat Genet 50:460-471

Showing the most recent 10 out of 322 publications